Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial.

Saved in:
Bibliographic Details
Title: Phase IV adaptive randomised clinical trials evaluating efficacy and cost-efficacy of pre-emptive pharmacogenetic genotyping strategies in the Spanish National Health System: iPHARMGx Master Protocol and PREVESTATGx nested clinical trial.
Authors: Stewart S; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Seco-Meseguer E; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Diago-Sempere E; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Marín-Candón A; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Carmona M; Unidad de Investigación en Telemedicina y e-Salud, Instituto de Salud Carlos III, Madrid, Spain., Estébanez M; Internal Medicine Department, Hospital Central de la Defensa Gomez Ulla, Madrid, Spain., López-Fernández LA; Pharmacy Department, Instituto de Investigación Sanitaria Gregorio Marañón, Hospital General Universitario Gregorio Maranon, Madrid, Spain.; Plataforma SCReN (Spanish Clinical Research Network), Madrid, Spain., Imaz-Iglesia I; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain.; Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Madrid, Spain., Del Mar García Saiz M; Clinical Pharmacology Service, Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain., Laserna-Mendieta EJ; Department of Gastroenterology, Research Unit, Hospital General de Tomelloso, Tomelloso, Castilla-La Mancha, Spain.; Instituto de Investigación Sanitaria de Castilla La Mancha, Toledo, Castilla La Mancha, Spain., Peiró AM; Unidad de Farmacología Clínica, Unidad del Dolor, Alicante Department of Health-General Hospital, Alicante, Comunidad Valenciana, Spain., Farré M; Department of Clinical Pharmacology, Pharmacogenomics Unit, Hospital Germans Trias i Pujol, Badalona, Catalunya, Spain.; Department of Pharmacology, Universitat Autonoma de Barcelona, Cerdanyola del Vallès, Catalunya, Spain., Rodriguez-Jimenez C; Clinical Trials Unit, Pharmacology Department, Hospital Universitario de Canarias, La Laguna, Canarias, Spain.; Complejo Hospital Universitario de Canarias, UICEC, La Laguna, Spain., Saiz-Rodriguez M; Research Unit, Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain., Sanabria-Cabrera J; Servicio de Farmacología Clínica, IBIMA Plataforma BIONAND, Universidad de Málaga, Málaga, Spain, Platform for Clinical Research and Clinical Trials IBIMA, Hospital Universitario Virgen de la Victoria, Malaga, Andalucía, Spain., Rosas-Alonso R; Pharmacogenetics Laboratory, Genetics Department, Hospital Universitario La Paz, Madrid, Spain., Abad-Santos F; UICEC Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IP), Hospital Universitario de la Princesa, Madrid, Spain., Pedrosa L; Health Technology Assessment Agency (AETS), Instituto de Salud Carlos III, Madrid, Spain., Carcas AJ; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., García García I; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain., Borobia AM; Clinical Pharmacology Department, Hospital Universitario La Paz, Madrid, Spain alberto.borobia@salud.madrid.org.; Pharmacology Department. School of Medicine, Autonomous University of Madrid, Madrid, Spain.
Corporate Authors: iPHARMGx study group
Source: BMJ open [BMJ Open] 2024 Nov 07; Vol. 14 (11), pp. e089823. Date of Electronic Publication: 2024 Nov 07.
Publication Type: Journal Article; Clinical Trial Protocol
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2044-6055
DOI:10.1136/bmjopen-2024-089823